Search - tctmd.com

Displaying 421 - 440 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder

October 30, 2016

Presentation TCT 2016

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? No for All Practical Purposes the Outcomes Are Similar!

Presenter: Manel Sabate, Robert-Jan van Geuns, Julinda Mehilli

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri

October 30, 2016

Presentation TCT 2016

Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study

Presenter: Peter Juni, E. Magnus Ohman, Ori Ben-Yehuda

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White

October 30, 2016

Presentation TCT 2016

Clinical Trial Interpretation: Relative vs Absolute Differences

Presenter: Peter Juni, E. Magnus Ohman, John A. Bittl

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes

Presenter: Dean J. Kereiakes, Pieter C. Smits, Upendra Kaul

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Levels of Evidence: Single-center vs Multicenter Trials

Presenter: Peter Juni, E. Magnus Ohman, Roxana Mehran

October 30, 2016

Presentation TCT 2016

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack

October 30, 2016

Presentation TCT 2016

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams

October 30, 2016

Presentation TCT 2016

Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update on Recent New Generation DES

Presenter: Dean J. Kereiakes, Pieter C. Smits, Stefan K. James

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Neil E. Moat

October 30, 2016

Presentation TCT 2016

Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint?

Presenter: Peter Juni, E. Magnus Ohman, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation TCT 2016

Comparative DES Outcomes: What Have We Learned From 7 SORT-OUT Trials?

Presenter: Dean J. Kereiakes, Pieter C. Smits, Lisette Okkels Jensen

October 30, 2016

Presentation TCT 2016

The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines) Into Changes in Clinical Practice

Presenter: Roxana Mehran, Pascal Vranckx

October 30, 2016

Advertisement

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? No for All Practical Purposes the Outcomes Are Similar!

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Clinical Trial Interpretation: Relative vs Absolute Differences

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Levels of Evidence: Single-center vs Multicenter Trials

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update on Recent New Generation DES

Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study

Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint?

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Comparative DES Outcomes: What Have We Learned From 7 SORT-OUT Trials?

The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines) Into Changes in Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content